Cigna Investments’s Phillips 66 PSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $629K | Sell |
3,724
-101
| -3% | -$17.4K | 0.08% | 215 |
|
|
2026
Q1 | $697K | Sell |
3,825
-128
| -3% | -$20.1K | 0.11% | 179 |
|
|
2025
Q4 | $510K | Sell |
3,953
-48
| -1% | -$6.46K | 0.07% | 230 |
|
|
2025
Q3 | $544K | Hold |
4,001
| – | – | 0.08% | 222 |
|
|
2025
Q2 | $477K | Sell |
4,001
-128
| -3% | -$14.3K | 0.08% | 235 |
|
|
2025
Q1 | $510K | Sell |
4,129
-185
| -4% | -$22.8K | 0.09% | 212 |
|
|
2024
Q4 | $491K | Sell |
4,314
-80
| -2% | -$10.2K | 0.09% | 221 |
|
|
2024
Q3 | $578K | Sell |
4,394
-45
| -1% | -$6.08K | 0.1% | 194 |
|
|
2024
Q2 | $626K | Sell |
4,439
-189
| -4% | -$28K | 0.12% | 171 |
|
|
2024
Q1 | $756K | Sell |
4,628
-122
| -3% | -$17.6K | 0.14% | 148 |
|
|
2023
Q4 | $633K | Sell |
4,750
-184
| -4% | -$22K | 0.13% | 157 |
|
|
2023
Q3 | $593K | Sell |
4,934
-703
| -12% | -$78.9K | 0.14% | 153 |
|
|
2023
Q2 | $537K | Sell |
5,637
-71
| -1% | -$6.9K | 0.1% | 199 |
|
|
2023
Q1 | $579K | Sell |
5,708
-135
| -2% | -$13.7K | 0.12% | 181 |
|
|
2022
Q4 | $608K | Sell |
5,843
-50
| -0.8% | -$5.11K | 0.13% | 172 |
|
|
2022
Q3 | $476K | Sell |
5,893
-280
| -5% | -$23.9K | 0.11% | 198 |
|
|
2022
Q2 | $507K | Sell |
6,173
-2,014
| -25% | -$186K | 0.1% | 201 |
|
|
2022
Q1 | $708K | Sell |
8,187
-1,644
| -17% | -$138K | 0.09% | 226 |
|
|
2021
Q4 | $713K | Sell |
9,831
-3,624
| -27% | -$274K | 0.06% | 288 |
|
|
2021
Q3 | $942K | Sell |
13,455
-200
| -1% | -$14.5K | 0.07% | 261 |
|
|
2021
Q2 | $1.17M | Sell |
13,655
-2,100
| -13% | -$177K | 0.08% | 212 |
|
|
2021
Q1 | $1.28M | Buy |
15,755
+500
| +3% | +$39.2K | 0.09% | 209 |
|
|
2020
Q4 | $1.07M | Buy |
15,255
+1,220
| +9% | +$71.6K | 0.08% | 225 |
|
|
2020
Q3 | $727K | Sell |
14,035
-26
| -0.2% | -$1.59K | 0.07% | 259 |
|
|
2020
Q2 | $1.01M | Buy |
14,061
+1,512
| +12% | +$107K | 0.1% | 192 |
|
|
2020
Q1 | $673K | Sell |
12,549
-13,540
| -52% | -$1.1M | 0.09% | 250 |
|
|
2019
Q4 | $2.38M | Sell |
26,089
-1,454
| -5% | -$163K | 0.25% | 79 |
|
|
2019
Q3 | $3.22M | Buy |
27,543
+1,326
| +5% | +$133K | 0.33% | 63 |
|
|
2019
Q2 | $2.69M | Buy |
26,217
+59
| +0.2% | +$5.29K | 0.29% | 68 |
|
|
2019
Q1 | $2.49M | Buy |
26,158
+10,738
| +70% | +$1.02M | 0.28% | 72 |
|
|
2018
Q4 | $1.33M | Buy |
15,420
+87
| +0.6% | +$8.5K | 0.11% | 128 |
|
|
2018
Q3 | $1.58M | Buy |
15,333
+1,860
| +14% | +$215K | 0.13% | 121 |
|
|
2018
Q2 | $1.51M | Sell |
13,473
-1,929
| -13% | -$217K | 0.11% | 162 |
|
|
2018
Q1 | $1.48M | Sell |
15,402
-507
| -3% | -$49.4K | 0.1% | 167 |
|
|
2017
Q4 | $1.61M | Sell |
15,909
-850
| -5% | -$80.8K | 0.11% | 145 |
|
|
2017
Q3 | $1.53M | Sell |
16,759
-19
| -0.1% | -$1.61K | 0.1% | 150 |
|
|
2017
Q2 | $1.39M | Sell |
16,778
-1,685
| -9% | -$132K | 0.1% | 171 |
|
|
2017
Q1 | $1.46M | Buy |
18,463
+2,048
| +12% | +$165K | 0.1% | 168 |
|
|
2016
Q4 | $1.42M | Buy |
+16,415
| New | +$1.36M | 0.15% | 154 |
|
Other funds holding PSX
EIM
Cigna Investments's PSX Position: Q2 2026 in Review
Cigna Investments reduced its Phillips 66 (PSX) stake by 2.6% in Q2 2026, selling an estimated $17.4K and leaving 3,724 shares worth $629K. The position accounts for 0.08% of the portfolio, ranked #215.
Cigna Investments first reported a position in PSX in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.22M in Q3 2019. 2,097 funds tracked by Wall St. Rank hold PSX as of Q2 2026.
- Cigna Investments held 3,724 shares of Phillips 66 worth $629K as of Q2 2026.
- Cigna Investments sold 101 Phillips 66 shares in Q2 2026, an estimated $17.4K.
- Phillips 66 made up 0.08% of Cigna Investments's portfolio in Q2 2026, its #215 holding.
- Cigna Investments first reported a position in Phillips 66 in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Phillips 66 position peaked at $3.22M in Q3 2019.
- 2,097 funds tracked by Wall St. Rank held Phillips 66 as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.